港股异动|中芯国际涨逾6%Q2净利环比增51%至1853.9万美元
格隆汇8月9日丨中芯国际(0981.HK)迅速走高,现报9.22港元,涨6.47%,暂成交1.81亿港元,最新总市值465.77亿港元。中芯国际昨晚公布的财报显示,第二季度营收7.909亿美元,环比增长18.2%,同比减少11.2%,市场预估7.893亿美元;第二季度净利润1853.9万美元,环比增长51.1%,同比减少64.1%,市场预估3830万美元;毛利率19.1%,环比上升0.9个百分点,而上年同期为24.5%。公告称,销售额环比增长主要由于今年第二季晶圆付运量增加所致。公司预期,第三季度收入增加0%至2%,及不含阿韦扎诺晶圆厂增加2%至4%;毛利率在19%至21%之间。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.